Vertex downgraded to Peer Perform from Outperform at Wolfe Research
Wolfe Research analyst Andy Chen downgraded Vertex Pharmaceuticals (VRTX) to Peer Perform from Outperform.
Protect Your Portfolio Against Market Uncertainty
Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
an hour ago
- Business Insider
Mizuho Securities Remains a Buy on Micron (MU)
Mizuho Securities analyst Vijay Rakesh maintained a Buy rating on Micron (MU – Research Report) yesterday and set a price target of $150.00. The company's shares closed yesterday at $127.25. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter According to TipRanks, Rakesh is a 5-star analyst with an average return of 15.9% and a 55.00% success rate. Rakesh covers the Technology sector, focusing on stocks such as Credo Technology Group Holding Ltd, Broadcom, and Nvidia. In addition to Mizuho Securities, Micron also received a Buy from Bernstein's Mark Li in a report issued on June 23. However, on June 20, Morgan Stanley maintained a Hold rating on Micron (NASDAQ: MU). MU market cap is currently $136.4B and has a P/E ratio of 29.34.
Business Insider
an hour ago
- Business Insider
Kepler Capital Keeps Their Buy Rating on Pernod Ricard (0HAT)
In a report released on June 24, Richard Withagen from Kepler Capital maintained a Buy rating on Pernod Ricard (0HAT – Research Report), with a price target of €117.00. The company's shares closed last Tuesday at €87.34. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter According to TipRanks, Withagen is an analyst with an average return of -1.1% and a 43.99% success rate. Withagen covers the Consumer Defensive sector, focusing on stocks such as Remy Cointreau, Davide Campari-Milano SpA, and Diageo. Currently, the analyst consensus on Pernod Ricard is a Moderate Buy with an average price target of €108.93.
Business Insider
an hour ago
- Business Insider
Kepler Capital Sticks to Their Buy Rating for Saipem SpA (SPEA)
Kepler Capital analyst Kevin Roger maintained a Buy rating on Saipem SpA (SPEA – Research Report) on June 24 and set a price target of €3.60. The company's shares closed last Monday at €2.43. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter According to TipRanks, Roger is a 5-star analyst with an average return of 14.6% and a 65.33% success rate. Roger covers the Energy sector, focusing on stocks such as Saipem SpA, Subsea 7, and Gaztransport et technigaz. Currently, the analyst consensus on Saipem SpA is a Strong Buy with an average price target of €3.25. The company has a one-year high of €2.75 and a one-year low of €1.65. Currently, Saipem SpA has an average volume of 3,771. Based on the recent corporate insider activity of 7 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of SPEA in relation to earlier this year.
